Related Experiment Video
Updated: Jan 12, 2026

Development and Characterization of Fusidic Acid-Loaded Alginate-Aloe vera Based Hydrogel FilmWound Healing
Published on: December 13, 2024
Injectable Hyaluronic Acid Hydrogels Crosslinked by Structure-engineered Aldehyde-functionalized β-Cyclodextrin
Chao Yang1,2, Meng Xin3, Yufu Jiang1
1College of Materials Science and Engineering, Qingdao University, Qingdao, 266071, Shandong, China.
Injectable hyaluronic acid hydrogels offer long-term controlled drug release for ocular diseases. These novel β-cyclodextrin-based hydrogels demonstrate excellent biocompatibility and sustained drug delivery over 60 days.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Ophthalmology
Background:
- Long-term controlled drug release from injectable hydrogels for ocular diseases remains a significant challenge.
- Existing treatments often require frequent injections, impacting patient compliance and therapeutic outcomes.
Purpose of the Study:
- To develop and characterize novel injectable hyaluronic acid (HA)-based hydrogels for sustained ocular drug delivery.
- To investigate the influence of different aldehyde-functionalized β-cyclodextrin (β-CD) derivatives on hydrogel properties and drug release kinetics.
Main Methods:
- Synthesis of injectable HA-based hydrogels via Schiff base reaction between amino-functionalized HA (NHA) and three aldehyde-functionalized β-CD derivatives (ACD, ALCD, ABCD).
- Characterization of hydrogel composition, structure, and properties using FTIR, SEM, and dynamic rheometry.
- Evaluation of drug release profiles (Voriconazole) and cellular compatibility of the developed hydrogels.
Main Results:
- The synthesized hydrogels exhibited suitable microstructural and rheological properties for injection, with pore sizes of 50-250 μm and gelation times of 60-300 s.
- The hydrogels achieved long-term controlled release of Voriconazole for over 60 days with quasi-zero-order kinetics in the later stage.
- Excellent cellular compatibility was observed, particularly for NHA/ACD and NHA/ABCD hydrogel formulations.
Conclusions:
- Injectable HA-based hydrogels functionalized with aldehyde-β-CD derivatives show significant potential for long-term controlled drug delivery in treating chronic ocular diseases.
- The study provides valuable insights into the structure-property relationships of β-CD derivatives for designing advanced injectable drug delivery systems.
- These hydrogels offer a promising platform for sustained therapy, potentially reducing the need for frequent ocular injections.
More Related Videos
09:39Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
Published on: February 7, 2021
12:07Fabricating Degradable Thermoresponsive Hydrogels on Multiple Length Scales via Reactive Extrusion, Microfluidics, Self-assembly, and Electrospinning
Published on: April 16, 2018
Related Concept Videos
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention